Scientists track rare bone disease patients for 5 years to see if treatment stops working
NCT ID NCT05234567
Summary
This study aims to understand if the immune system of patients with a rare bone disease, hypophosphatasia, can stop their main treatment, asfotase alfa, from working or cause severe allergic reactions. It will follow about 30 patients, including children and adults, for at least five years. Researchers will monitor patients' health and check their blood for signs that their body is fighting the medicine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOPHOSPHATASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Trial Site
RECRUITINGHartford, Connecticut, 06106, United States
-
Clinical Trial Site
RECRUITINGChicago, Illinois, 60611, United States
-
Clinical Trial Site
RECRUITINGBoston, Massachusetts, 02122, United States
-
Clinical Trial Site
RECRUITINGKansas City, Missouri, 64108, United States
-
Clinical Trial Site
RECRUITINGMineola, New York, 11501, United States
-
Clinical Trial Site
NOT_YET_RECRUITINGCincinnati, Ohio, 45229, United States
-
Clinical Trial Site
RECRUITINGColumbus, Ohio, 43203, United States
-
Clinical Trial Site
NOT_YET_RECRUITINGPittsburgh, Pennsylvania, 15224, United States
-
Clinical Trial Site
RECRUITINGNashville, Tennessee, 37112, United States
-
Clinical Trial Site
RECRUITINGSalt Lake City, Utah, 84108, United States
-
Clinical Trial Site
RECRUITINGCharlottesville, Virginia, 22903, United States
-
Clinical Trial Site
RECRUITINGMadison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.